Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

11568 from 12310 pages
No results were found for the filter!
Antitumor agent-75
Antitumor agent-75

Item number: TGM-T62510-100mg

Description: Antitumor agent-75 is a novel and potent antitumor agent with cytotoxic effects on both cancer and normal human cell lines. In combination with antitumor agent-74, Antitumor agent-75 exhibits a highly selective cytotoxic effect (IC50: 2.8 µM) against human lung adenocarcinoma [cell line A549]. Antitumor...
MW: 438.5 D
From 1,440.00€ *
Review
Imidocarb dihydrochloride monohydrate
Imidocarb dihydrochloride monohydrate

Item number: TGM-T62520-100mg

Description: Imidocarb dihydrochloride monohydrate is an effective antiprotozoal agent against the parasite B. bovis (IC50: 87 µg/ml). Target: Others
MW: 439.34 D
From 1,440.00€ *
Review
HIV-1 inhibitor-8
HIV-1 inhibitor-8

Item number: TGM-T62526-100mg

Description: HIV-1 inhibitor-8 is a potent, orally active, low toxicity HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI). HIV-1 inhibitor-8 is capable of acting on WT HIV-1 reverse transcriptase (IC50: 0.081 µM). HIV-1 inhibitor-8 exhibited potent antiviral effects against various HIV-1 strains with EC50...
MW: 439.53 D
From 903.00€ *
Review
Dopamine D3 receptor ligand-1
Dopamine D3 receptor ligand-1

Item number: TGM-T62528-100mg

Description: Dopamine D3 receptor ligand is a potent, selective, high-affinity compound with 89 times greater selectivity for D3 receptors (Ki: 8 nM) compared to D2 receptors (Ki: 715 nM). Target: Others
MW: 439.55 D
From 1,440.00€ *
Review
Antimalarial agent 7
Antimalarial agent 7

Item number: TGM-T62537-100mg

Description: Antimalarial agent 7 is a potent and effective inhibitor of PfATP4, showing potential for studying human Plasmodium falciparum. Target: Others
MW: 440.44 D
From 1,440.00€ *
Review
PARP1/BRD4-IN-2
PARP1/BRD4-IN-2

Item number: TGM-T62540-100mg

Description: PARP1/BRD4-IN-2 is a potent and selective inhibitor of PARP1 (IC50: 197 nM) and BRD4 (IC50: 238 nM), which inhibits DNA damage repair, blocks the G0/G1 cell cycle transition, and induces apoptosis. PARP1/BRD4-IN-2 exhibits antitumor effects in the MDA-MB-468 mouse xenograft tumor model and is used to...
MW: 440.45 D
From 1,440.00€ *
Review
AChE-IN-22
AChE-IN-22

Item number: TGM-T62541-100mg

Description: AChE-IN-22 (compound 10q) is a selective acetylcholinesterase (AChE) inhibitor with IC50 values of 0.88 µM for AChE and 10 µM for BuChE. It binds to both the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE and is used in Alzheimer's disease research. Target: Others
MW: 440.47 D
From 1,440.00€ *
Review
DSM705 hydrochloride
DSM705 hydrochloride

Item number: TGM-T62550-100mg

Description: DSM705 hydrochloride is a potent antimalarial compound and a pyrrole-based inhibitor of dihydroorotate dehydrogenase (DHODH).DSM705 hydrochloride shows nanomolar effects against PlasmodiumDHODH and Plasmodium parasites and does not inhibit mammalian DHODH. Target: Others
MW: 440.85 D
From 1,127.00€ *
Review
PPARgamma phosphorylation inhibitor 1
PPARgamma phosphorylation inhibitor 1

Item number: TGM-T62554-100mg

Description: PPARgamma phosphorylation inhibitor 1 (Compound 10) is a potent PPARgamma binding agent (IC50: 24 nM) with antidiabetic effects, inhibiting CDK5-mediated PPARgamma Ser273 phosphorylation (IC50: 160 nM) and displaying minimal PPARgamma agonism. Target: Others
MW: 441.26 D
From 1,440.00€ *
Review
JAK-IN-23
JAK-IN-23

Item number: TGM-T62556-100mg

Description: JAK-IN-23 is an orally active dual JAK/STAT and NF-kappaB inhibitor that inhibits JAK1 (IC50: 8.9 nM), JAK2 (IC50: 15 nM), and JAK3 (IC50: 46.2 nM). It exhibits strong anti-inflammatory effects and can reduce the release of various pro-inflammatory factors. JAK-IN-23 can be used to study inflammatory...
MW: 441.35 D
From 867.00€ *
Review
Mu opioid receptor antagonist 5
Mu opioid receptor antagonist 5

Item number: TGM-T62673-100mg

Description: Mu opioid receptor antagonist 5 (compound NAP) is a selective mu opioid receptor (MOR) antagonist that crosses the blood-brain barrier, with an EC50 of 1.14 nM and a Ki of 0.37 nM. Mu opioid receptor antagonist 5 can be used to study opioid use disorder (OUD). Target: Others
MW: 447.53 D
From 1,440.00€ *
Review
LSD1-IN-21
LSD1-IN-21

Item number: TGM-T62674-100mg

Description: LSD1-IN-21 is a potent, blood-brain barrier permeable LSD1 (lysine specific demethylase-1) inhibitor (IC50: 0.956 µM).LSD1-IN-21 significantly reduces the pro-inflammatory cytokine TNF-alpha and exhibits good anti-cancer and anti-inflammatory effects. Target: Others
MW: 447.55 D
From 1,440.00€ *
Review
11568 from 12310 pages